States use Preferred Drug Lists, pharmacist substitution rules, and copay differences to push generic drug use. These policies save billions without compromising care - but unintended rebate rules are putting some generics at risk.
Emotional blunting from SSRIs affects up to 60% of users, causing numbness, loss of joy, and detachment. Learn why it happens, who it impacts most, and evidence-based solutions like dose reduction and switching to bupropion.
Learn how the FDA's 2025 update to biosimilar approval rules is accelerating access to lower-cost biologic alternatives, why they're not the same as generics, and what this means for patients and providers.
Medication synchronization aligns all monthly refills to one date, preventing dangerous therapy gaps for complex regimens. Learn practical steps, eligibility criteria, and real-world impact on adherence.
Generic drugs make up 90% of prescriptions but only 20% of spending - and that’s why they’re disappearing. Cheap prices, foreign factories, and broken incentives are causing critical drug shortages affecting millions.